NCT06257329 (COPDregister) is a clinical trial of register in COPD Exacerbation, sponsored by Alexis FERRE.

Who is sponsoring NCT06257329?

NCT06257329 is sponsored by Alexis FERRE.

What drugs are being tested in NCT06257329?

Interventions in NCT06257329: register.

What condition does NCT06257329 study?

NCT06257329 studies COPD Exacerbation.

Is NCT06257329 still recruiting?

NCT06257329 is currently recruiting now. Last updated 13 February 2024.

Last reviewed 2024-02-13 · How we verify

NCT06257329: COPDregister

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.

Recruiting now Last updated 13 February 2024

What this trial tests

trial testing register in COPD Exacerbation in 2,000 participants. Currently enrolling.

Timeline

1 October 2022

Primary endpoint
1 October 2027

1 April 2028

Quick facts

Lead sponsor	Alexis FERRE
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 October 2022
Primary completion	1 October 2027
Estimated completion	1 April 2028
Sites	2 locations across France

Drugs / interventions tested

Conditions studied

COPD Exacerbation — all drugs for COPD Exacerbation →

Sponsor

Alexis FERRE

Who can join

40 and older, any sex, with COPD Exacerbation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for COPD Exacerbation

Currently open trials in the same condition.

NCT07351929 — Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD · NA · recruiting
NCT05703919 — Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease · Phase 4 · recruiting
NCT06347536 — Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease · Phase 3 · recruiting
NCT06691399 — Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients · NA · recruiting
NCT05958563 — Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06257329 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexis FERRE
Last refreshed: 13 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06257329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing